pentobarbital will minimize the level or outcome of bedaquiline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Avoid coadministration of bedaquiline with sturdy CYP3A4 inducers on account of prospective for lowered therapeutic impactpentobarbital will lower the level or result of dasatinib by impacti